Friday | November 22, 2024 - AGENDA
9:00 - 12:00 PM
Morning Startup Bootcamp
9:00 AM
Opening Remarks
Presented By:
Sharon Bakalash, MD, PhD
9:05 AM
IP Protection Tutorial
Participant:
Martin J. Waters, Partner – Wilson Sonsini
9:25 AM
Case Study 1: Crossing the Valley of Death
Pre-Clinical – Clinical
Presentation:
David Sharp, PhD, Co-Founder & Chief Science Officer – Microcures
Mentor:
Eric Schlumpf, President & CEO - Stuart Therapeutics
Panelists:
David Almeida, MD, PhD, MBA, President & CEO - Erie Retina Research | CASExGLOBAL
Rob Rothman, MD, Co-Founder, Co-Managing Member / Partner - InFocus Capital Partners / OCLI - Glaucoma Consultants of Long Island
Eric Schlumpf, President & CEO - Stuart Therapeutics
10:10 AM
Designing Clinical Trials of the Future
Presented By:
David Almeida, MD, PhD, MBA, President & CEO - Erie Retina Research | CASExGLOBAL
10:20 AM
Trials, Tribulations, and Triumph: Navigating the Path to Market
Participant:
Tracy Valorie, MBA, Founder - TMV Associates
10:40 AM
Case Study 2: Funding Challenges for “Platform Technologies”
Presentation:
Robert Molinari, PhD, MBA,Co-founder/Director - Repoxegen Therapeutics
Mentor:
Riad Sherif, MD, CEO – Oculis
Panelists:
David Esposito, CEO - ONL Therapeutics
James Murray, Managing Partner - ExSight Ventures
Riad Sherif, MD, CEO – Oculis
11:20 AM
Finding the Needle in the Haystacks: The do's and Don'ts of Startup/investor Strategies
11:45 - 12:30 PM
Check-in and Networking Lunch
12:30 - 12:35 PM
Welcome & Opening Remarks
12:35 - 2:00 PM
New Innovation Showcase
AiViva BioPharma | Diane Tang-Liu, PhD, President & CEO
Near-Real Surgical Specimens | David Almeida, MD, MBA, PhD, CEO
LEP Biomedical | Alan Hibbitts, PhD, CEO & Founder
Ocudyne | Jeff Franco, CEO
GlaucoT | Abdulkadir Oduncu, MD, CSO & Co-founder
Viridian Therapeutics | Thomas Ciulla, MD, MBA, Chief Medical Officer
Sustained Drug Delivery | Vicente Diaz, MD, Managing Member
KEJAKO | Gilles Bos, Co-Founder & Investor
OptiVize | James Rynerson, MD, CEO
Theialife | Patricia Zilliox, PhD, Advisor
Ascidian Therapeutics | Dan Rosan, MBA, Chief Business & Financial Officer
2:00 - 2:35 PM
How to Tackle Functional Endpoints in a GA study
Panelists:
Mayssa Attar, PhD, SVP, Pharma/Consumer R&D Head - Bausch + Lomb
Karl Csaky, MD, PhD, Chief Executive and Medical Officer - Retina Foundation of the Southwest
Daniela Ferrara, MD, MS, PhD, FASRS, Principal Medical Director, Ophthalmology Imaging Lead, Product Development, Analytics and Medical Imaging - Genentech a member of the Roche Group
Mike Mbagwu, MD, Global Medical Lead/Medical Director, Cell and Gene Therapy - Astellas Pharma
Stephen Poor, Executive Director, Translational Development - Apellis
Moderated By:
Erin C. Henry, PhD, Biotech Executive/Clinical Researcher and Strategist
2:35 - 3:05 PM
Networking Break
3:05 - 4:05 PM
Innovating Together: Driving Solutions for Ophthalmic Challenges with CCOI – Collaborative Community on Ophthalmic Innovation
Introduction Presented By:
Malvina Eydelman, MD
Panelists:
Michael Abramoff, MD, PhD, Professor of Ophthalmology and Visual Sciences - University of Iowa School of Medicine
Natalie Afshari, MD, FACS, Professor of Ophthalmology and Chief of Cornea and Refractive Surgery - UC San Diego Shiley Eye Institute
Malvina Eydelman, MD, Director of the Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices - FDA
Jeffrey Goldberg, MD, PhD, Professor and Chair of Ophthalmology - Byers Eye Institute
Daniela Ferrara, MD, MS, PhD, FASRS, Principal Medical Director, Ophthalmology Imaging Lead, Product Development, Analytics and Medical Imaging - Genentech a member of the Roche Group
David Myung, MD, PhD, Associate Professor of Ophthalmology - Byers Eye Institute at Stanford University School of Medicine
Moderated By:
Robert Rothman, MD, Co-Founder and Co-Managing Member - InFocus Capital Partners / Partner, OCLI - Glaucoma Consultants of Long Island
4:05 - 4:40 PM
Investor Strategy
Understanding your investors and your investment strategies
Panelists:
Anna Chen, PhD, Principal - Frazier Life Sciences
Jeffrey Friedman, MD, PhD, Managing Partner - Friedman BioVenture
Joe Markson, PhD, Principal - Novo Holdings
Zach Scheiner, PhD, Principal - RA Capital Management
Co-Moderated By:
Paul Bresge, CEO - Ray Therapeutics
Jason Jun, Managing Director, Healthcare Investment Banking - Citi
4:40 - 5:30 PM
Gene & Cell Therapy Showcase
Aurion Biotech | Greg Kunst, CEO, Founder & Board Director
Emmecell | Jeffrey Goldberg, MD, PhD, Co-founder & Director of the Board of Managers
Ray Therapeutics | Peter Francis, MD, Chief Medical & Scientific Officer
Adverum Biotechnologies | Peter Soparkar, Chief Operating Officer
4DMT | Carlos Quezada-Ruiz, MD, FASRS, Senior Vice President, Clinical Research and Development, and Therapeutic Area Head, Ophthalmology
Eyegenex | Prasad Sunkara, President & CEO
Astellas | Sharon Bakalash, MD, PhD, Global Medical Affairs Head
5:30 - 6:00 PM
Bridging the Gaps: Driving Eye Innovation from Front to Back
Navigating Innovation Cycles and Predicting the Future of Eye Care
Panelists:
Eugene de Juan, MD, Professor - UCSF Department of Ophthalmology
David LeCause, Former Vice President Allergan Eye Care Business Unit; Strategic Advisor - Ophthalmic Pharmaceuticals I Biotech I Drug Delivery I Med Device
Jai G Parekh, MD, MBA, Chief Commercial Officer - Nordic Pharma Eye Care /Co-Founder, EyeCare Consultants of NJ
Sharon Bakalash, MD, PhD, CEO & Founder - SB Strategic Development Consultants
Ram Palanki, PharmD, Executive Vice President of Commercial Strategy & Operations - REGENXBIO
Moderated By:
Andrew Stewart, President, Global Pharmaceuticals and International Consumer - Bausch + Lomb
6:00 - 7:00 PM
Networking Reception
Saturday | November 23, 2024 - AGENDA
7:30 - 8:30 AM
Networking Breakfast & Check-In
8:30 - 8:35 AM
Opening Remarks
8:35 - 10:15 AM
Anterior Innovation Showcase
Lenz Therapeutics | Marc Odrich, MD, Chief Medical Officer
Seinda Biomedical | Jing-Feng Huang, Founder & CEO
Horizon Surgical Systems | Jean-Pierre Hubschman, MD, Co-Founder & CEO
Lubris Biopharma | Edward R Truitt. III, CEO
EYE-GO A/S | Henrik Nagel, CEO
Nanodropper | Mackenzie Andrews, Chief Commercial Officer
Bio-Tissue | Tom Williamson, Chief Commercial Officer
Novasight | Ran Yam, CEO & Co-Founder
AesculaTech | Adam Griese, Director
Mediprint Ophthalmics | Sanjeev Ganatra, Advisor, Corporate & Clinical
ECI Therapeutics | Ronald C. Gentile, MD, Founder & CMO
Visus Therapeutics | Ben Bergo, CEO
Stuart Therapeutics | Eric Schlumpf, President & CEO
10:15 - 10:50 AM
Future of Anterior Innovation: A Panel of Disruptors and Visionaries
Panelists:
Susan Benton, MBA, Board of Directors - Tarsier Pharma
Liane Clamen, MD, Founder & CEO - Adaptilens
Morgan Micheletti, MD, Partner, Director of Research, and Fellowship Director - Berkeley Eye Center
Patrick Mooney, CEO - SpyGlass Pharma
Cari Stone, SVP - Elios Vision
Moderated By:
Anthony Wallace, Vice President & General Manager - Bausch + Lomb
10:50 - 11:20 AM
Morning Networking Break
11:20 - 12:55 PM
Retina Innovation Showcase
Oculis | Riad Sherif, MD, CEO
Ocular Therapeutix | Sanjay Nayak, MBBS, PhD, Chief Strategy Officer
Valitor | Wesley M. Jackson, PhD, President & CSO
ONL Therapeutics | Connie Chang, MBA, Chief Operating Officer
Opthea | Frederic Guerard, PharmD, CEO
VIAN Therapeutics | Juan Pablo Robles, CEO & Founder
Novaliq | Christian Roesky, PhD, CEO & Managing Director
Eyedaptic | Jay Cormier, Founder & CEO
FELIQS | Kenchiro Kuninobu, PhD, Co-founder & CEO
Alkeus Pharmaceuticals | Leonide Saad, PhD, Co-Founder & Chief Scientific Officer
Kiora Pharmaceuticals | Eric Daniels, MD, MBA, Chief Development Officer
Revopsis | Ramanath Bhandari, MD, Founder, CEO & Chairman
LumiThera | Clark E. Tedford, PhD, President & CEO
12:55 - 1:45 PM
Networking Lunch
1:45 - 2:55 PM
Spotlight on Suprachoroidal Drug Delivery
Overview
Presented By:
Thomas A. Ciulla, MD, MBA, FASR, Clinical Professor of Ophthalmology, Volunteer/Vitreoretinal Medicine and Surgery - Indiana University School of Medicine / Midwest Eye Institute
Uneedle | Jeroen Wissink, CEO
REGENXBIO | Steve Pakola, MD, CMO
Everads Therapy | Moshe Weinstein, Executive Chair & CEO
Aura Biosciences | Ross Goldstein, MD, MBA, Vice President, Medical Affairs
Clearside Biomedical | Rafael Andino, Senior Vice President, Engineering & Manufacturing
Expert Panel Discussion
Panelists:
Mark R. Barakat, MD, Director of Clinical Research - Retina Macula Institute of Arizona /Medical Director - Spectra Eye Institute / Clinical Assistant Prof - University of Arizona College of Medicine
Robert B. Bhisitkul, MD, PhD, Professor of Ophthalmology - University of California San Francisco School of Medicine
Kirstie R. Cole, Director of Sales - Bausch + Lomb
Co-Moderated By:
Thomas A. Ciulla, MD, MBA, FASR, Clinical Professor of Ophthalmology, Volunteer/Vitreoretinal Medicine and Surgery - Indiana University School of Medicine / Midwest Eye Institute
Emmett T. Cunningham Jr., MD, PhD, MPH, Executive Chairman - Eyconis / Senior Partner - HealthQuest Capital Management
2:55 - 3:20 PM
One Size Does Not Fit All: Rigorous Endpoint Selection for Clinical Trials
Where trials, low vision, and endpoints intersect
Presented By:
Rebecca Kammer, OD, PhD
3:20 - 3:50 PM
Glaucoma Spotlight: Innovation vs Standard of Care
Panelists:
Alexander Gebauer, MD, PhD, Co-Founder and Executive Chairman - Galimedix Therapeutics
Jeffrey Goldberg, MD, PhD, Professor and Chair of Ophthalmology - Byers Eye Institute
Adrienne Graves, PhD, Former CEO - Santen / Board of Directors, Harrow, Ocular Therapeutix, NVasc, Opus Genetics, Surface Ophthalmics, JelliSee, Implandata, Qlaris
Jessica Steen, OD, FAAO, Associate Professor - Nova Southeastern University
Moderated By:
Robert Rothman, MD, Co-Founder and Co-Managing Member - InFocus Capital Partners / Partner, OCLI - Glaucoma Consultants of Long Island
3:50 - 4:20 PM
Networking Break
4:20 - 5:00 PM
Reverse Pitch by Strategics
Panelists:
Amy Hopkin, PhD, Director, Search and Evaluation for Eye Care - AbbVie External Innovation
Tomas Navratil, PhD, Chief Development Officer - Glaukos
Tomo Oe, PhD, Scouting & Transaction Lead, Business Development - Astellas Pharma
Shannon Spock, Pharmaceutical Search and Evaluation Head, BD&L - Alcon
Anthony Wallace, Vice President & General Manager - Bausch + Lomb
Moderated By:
Firas Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group
5:00 - 5:30 PM
A View from the Street
Panelists:
Anupam Dalal, MD, Chief Investment Officer and Managing Member - Acuta Capital Partners
Andrew Gitkin, Senior Managing Director, Healthcare - Leerink Partners
Susan Orr, OD, Chief Medical Officer - Claris Bio
Cameron Taylor, Managing Director - BofA Securities | Life Sciences
Moderated By:
Pravin U. Dugel, MD, President, CEO & Executive Chairman - Ocular Therapeutix
5:30 - 7:00 PM